1. Home
  2. VMD vs HRTX Comparison

VMD vs HRTX Comparison

Compare VMD & HRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Viemed Healthcare Inc.

VMD

Viemed Healthcare Inc.

HOLD

Current Price

$7.23

Market Cap

276.0M

Sector

N/A

ML Signal

HOLD

Logo Heron Therapeutics Inc.

HRTX

Heron Therapeutics Inc.

HOLD

Current Price

$1.28

Market Cap

203.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VMD
HRTX
Founded
2006
1983
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
276.0M
203.5M
IPO Year
N/A
1987

Fundamental Metrics

Financial Performance
Metric
VMD
HRTX
Price
$7.23
$1.28
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$4.50
AVG Volume (30 Days)
147.5K
1.8M
Earning Date
11-05-2025
02-26-2026
Dividend Yield
N/A
N/A
EPS Growth
35.92
N/A
EPS
0.34
N/A
Revenue
$254,794,000.00
$155,097,000.00
Revenue This Year
$20.05
$8.98
Revenue Next Year
$17.44
$11.57
P/E Ratio
$21.41
N/A
Revenue Growth
18.89
12.60
52 Week Low
$5.93
$1.00
52 Week High
$8.62
$2.68

Technical Indicators

Market Signals
Indicator
VMD
HRTX
Relative Strength Index (RSI) 52.47 52.18
Support Level $7.13 $1.18
Resistance Level $7.62 $1.29
Average True Range (ATR) 0.17 0.07
MACD -0.04 -0.01
Stochastic Oscillator 19.27 50.00

Price Performance

Historical Comparison
VMD
HRTX

About VMD Viemed Healthcare Inc.

Viemed Healthcare Inc is a provider of medical equipment and home therapy to patients with respiratory disease, oxygen problems, sleep apnea and PAP treatment. The company also provides services such as respiratory disease management, neuromuscular care, in-home sleep testing and sleep apnea treatment, oxygen therapy, respiratory equipment rentals, and healthcare staffing services. The company generates majority its revenue from medical equipment rental, sales and supply.

About HRTX Heron Therapeutics Inc.

Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the lives of patients by developing treatments that address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.

Share on Social Networks: